Austad; Brian C.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Austad; Brian C..The latest application filed is for "process for preparing xpo1 inhibitors and intermediates for use in the preparation of xpo1 inhibitors".
- Austad; Brian C. - Tewksbury MA
| Patent | Date |
|---|---|
| Process For Preparing Xpo1 Inhibitors And Intermediates For Use In The Preparation Of Xpo1 Inhibitors App 20220242832 - Austad; Brian C. ; et al. | 2022-08-04 |
| Polymorphs Of Selinexor App 20220135545 - Austad; Brian C. ; et al. | 2022-05-05 |
| Polymorphs of selinexor Grant 11,078,190 - Austad , et al. August 3, 2 | 2021-08-03 |
| Polymorphs Of Selinexor App 20200283419 - Austad; Brian C. ; et al. | 2020-09-10 |
| Polymorphs of Selinexor Grant 10,519,139 - Austad , et al. Dec | 2019-12-31 |
| Methods Of Treating A Fatty Acid Amide Hydrolase-mediated Condition App 20180244700 - Austad; Brian C. ; et al. | 2018-08-30 |
| Polymorphs Of Selinexor App 20180215733 - Austad; Brian C. ; et al. | 2018-08-02 |
| Methods of treating a fatty acid amide hydrolase-mediated condition Grant 9,951,089 - Austad , et al. April 24, 2 | 2018-04-24 |
| Transfer hydrogenation of cyclopamine analogs Grant 9,879,025 - Genov , et al. January 30, 2 | 2018-01-30 |
| Enzymatic transamination of cyclopamine analogs Grant 9,879,293 - Austad , et al. January 30, 2 | 2018-01-30 |
| Transfer Hydrogenation Of Cyclopamine Analogs App 20170029433 - Genov; Daniel G. ; et al. | 2017-02-02 |
| Transfer hydrogenation of cyclopamine analogs Grant 9,394,313 - Genov , et al. July 19, 2 | 2016-07-19 |
| Transfer hydrogenation of cyclopamine analogs Grant 9,376,447 - Genov , et al. June 28, 2 | 2016-06-28 |
| Enzymatic Transamination Of Cyclopamine Analogs App 20160177354 - Austad; Brian C. ; et al. | 2016-06-23 |
| Methods for stereoselective reduction Grant 9,238,672 - Austad , et al. January 19, 2 | 2016-01-19 |
| Fatty Acid Amide Hydrolase Inhibitors App 20150239912 - AUSTAD; Brian C. ; et al. | 2015-08-27 |
| Fatty acid amide hydrolase inhibitors Grant 9,034,849 - Austad , et al. May 19, 2 | 2015-05-19 |
| Enzymatic Transamination of Cyclopamine Analogs App 20140371456 - Austad; Brian C. ; et al. | 2014-12-18 |
| Methods For Stereoselective Reduction App 20140357868 - Austad; Brian C. ; et al. | 2014-12-04 |
| Methods for stereoselective reduction Grant 8,716,479 - Austad , et al. May 6, 2 | 2014-05-06 |
| Enzymatic transamination of cyclopamine analogs Grant 8,703,448 - Austad , et al. April 22, 2 | 2014-04-22 |
| Ansamycin formulations and methods of use thereof Grant 8,357,676 - Austad , et al. January 22, 2 | 2013-01-22 |
| Ansamycin formulations and methods of use thereof Grant 8,283,343 - Austad , et al. October 9, 2 | 2012-10-09 |
| Enzymatic Transamination of Cyclopamine Analogs App 20120083607 - Austad; Brian c. ; et al. | 2012-04-05 |
| Transfer Hydrogenation of Cyclopamine Analogs App 20120065399 - Genov; Daniel G. ; et al. | 2012-03-15 |
| Transfer Hydrogenation of Cyclopamine Analogs App 20120065400 - Genov; Daniel G. ; et al. | 2012-03-15 |
| Fatty Acid Amide Hydrolase Inhibitors App 20110201574 - AUSTAD; Brian C. ; et al. | 2011-08-18 |
| Ansamycin formulations and methods of use thereof Grant 7,947,670 - Austad , et al. May 24, 2 | 2011-05-24 |
| Methods For Stereoselective Reduction App 20110009442 - Austad; Brian C. ; et al. | 2011-01-13 |
| Ansamycin formulations and methods of use thereof App 20090069281 - Austad; Brian C. ; et al. | 2009-03-12 |
| Ansamycin formulations and methods of use thereof App 20090062528 - Austad; Brian C. ; et al. | 2009-03-05 |
| Ansamycin formulations and methods of use thereof App 20080221077 - Austad; Brian C. ; et al. | 2008-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 